DurgicalDurgical
EN
Open the app

Familial hypercholesterolemia !

An inherited disorder in which the liver cannot clear LDL cholesterol from the blood; it causes early heart attacks if untreated.

Updated 2026-11-01

Structures involved

Tap one to see what it is and open it in 3D.

In biochemistry

In physiology

Why it happens

What it is

A genetic disorder, almost always autosomal dominant, with very high LDL from birth due to defects in the LDL receptor, ApoB or PCSK9.

Who gets it

It affects about 1 in 200 to 250 people worldwide and is the most common inherited cardiovascular disorder. Colombia and Latin America are thought to have a similar frequency, but most cases are undiagnosed. The homozygous form is very rare.

Causes

  • LDLR variants (most cases)
  • APOB variants that prevent receptor binding
  • Gain-of-function PCSK9 variants
  • Rarely, a recessive form due to LDLRAP1 variants

Risk factors

  • A parent with the condition (50% chance of inheriting it)
  • Family history of premature heart attack
  • Related parents (homozygous form)

Pathophysiology

With fewer working LDL receptors the liver takes up less LDL and, receiving less cholesterol, makes more. LDL circulates longer, is oxidised in the artery wall and forms plaques from childhood. It also deposits in tendons (xanthomas), eyelids and cornea.

Classification

  • Heterozygous: LDL often 190 mg/dL or more in adults
  • Homozygous or compound heterozygous: LDL often above 400–500 mg/dL, with coronary disease in childhood

Symptoms and signs

  • Often silent until coronary disease appears
  • Tendon xanthomas (thickened Achilles or hand extensor tendons)
  • Xanthelasma on the eyelids
  • Corneal arcus before age 45
  • Angina or heart attack at a young age

Diagnosis

Clinical
Suspected from very high LDL, xanthomas and family history; criteria such as the Dutch Lipid Clinic Network or Simon Broome are used.
Tests
Lipid panel; exclusion of secondary causes (TSH, glucose, kidney and liver function, proteinuria); genetic testing of LDLR, APOB and PCSK9; cascade screening of relatives.
Imaging
Carotid or Achilles tendon ultrasound; CT coronary calcium score; echocardiography in the homozygous form to assess the aortic valve and root.

Treatment

Lifestyle
Diet low in saturated fat, physical activity and no smoking, from childhood
Medical
High-intensity statins as the foundation
Medical
Ezetimibe and, if not enough, PCSK9 inhibitors or inclisiran
Procedure
LDL apheresis in the homozygous or resistant form
Medical
Lomitapide or evinacumab (anti-ANGPTL3) in the homozygous form, in specialist centres
Follow-up
Cascade screening of relatives and cardiovascular follow-up

Drugs for this condition

Complications

  • Premature coronary disease and heart attack
  • Supravalvular and valvular aortic stenosis (homozygous form)
  • Stroke
  • Peripheral artery disease

Prognosis

Untreated, about half of heterozygous men have coronary disease by age 50; early treatment brings the risk close to that of the general population.

Prevention

  • Cascade screening of a patient's relatives
  • Childhood cholesterol testing when there is a family history

Test yourself

Think of the answer, then tap the question to see it.

Which gene is altered in most cases of familial hypercholesterolaemia?

LDLR, the LDL receptor gene.

Which Achilles tendon finding suggests familial hypercholesterolaemia?

Thickening from a tendon xanthoma, caused by cholesterol deposits.

Why are a patient's relatives tested?

Inheritance is dominant: each child, sibling or parent is likely to have it and benefits from early treatment.

Why do some homozygous patients respond poorly to statins?

Statins lower LDL by increasing LDL receptors; with no working receptors the effect is small.

Add to my cards (4)

Educational information, not medical advice. For any symptom, see a health professional.

Sources: Familial hypercholesterolemia: MedlinePlus Genetics (MedlinePlus, US National Library of Medicine, 2026); Familial hypercholesterolemia: MedlinePlus Medical Encyclopedia (MedlinePlus, US National Library of Medicine, 2026); LDLR gene: MedlinePlus Genetics (MedlinePlus, US National Library of Medicine, 2026); PCSK9 gene: MedlinePlus Genetics (MedlinePlus, US National Library of Medicine, 2026).

← All conditions

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.

LAD (anterior descending artery) highlighted on the Durgical 3D model